Enterprise Products Partners Other Income (Expense) decreased by 2.4% to -$377.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.9%, from -$331.00M to -$377.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows relatively stable performance with a 1.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$315.00M | -$315.00M | -$326.00M | -$316.00M | -$307.00M | -$302.00M | -$285.00M | -$302.00M | -$283.00M | -$323.00M | -$320.00M | -$318.00M | -$328.00M | -$329.00M | -$328.00M | -$331.00M | -$325.00M | -$343.00M | -$368.00M | -$377.00M |
| QoQ Change | — | +0.0% | -3.5% | +3.1% | +2.8% | +1.6% | +5.6% | -6.0% | +6.3% | -14.1% | +0.9% | +0.6% | -3.1% | -0.3% | +0.3% | -0.9% | +1.8% | -5.5% | -7.3% | -2.4% |
| YoY Change | — | — | — | — | +2.5% | +4.1% | +12.6% | +4.4% | +7.8% | -7.0% | -12.3% | -5.3% | -15.9% | -1.9% | -2.5% | -4.1% | +0.9% | -4.3% | -12.2% | -13.9% |